JAGX -11% despite inking API-supply agreement with Glenmark Pharmaceuticals: http://finance.yahoo.com/news/jaguar-animal-health-signs-crofelemer-130500543.html The stock is now trading at less than half its May 2015 IPO price (#msg-113625541).